Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
A major Japanese labour union group said on Thursday its member unions had struck agreements for hefty wage hikes with ...
Ionis’ drug, called sapablursen, is currently being tested in a Phase 2 trial in people with polycythemia vera.
M&T Bank Corp lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 10.0% in the 4th ...
The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...
Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...
A Massachusetts man who, along with his girlfriend, defrauded Takeda Pharmaceutical Co. of $2.3 million and used the money to ...
Assetmark Inc. grew its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 6.4% in the fourth quarter, according to its most recent filing with the SEC.
Learn more about whether Recursion Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...
A Brockton man was sentenced for defrauding a pharmaceutical company out of $2.3 million and spending the proceeds on a ...
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...
Pharmaceutical Technology on MSN19h
Gedeon Richter’s once-daily endometriosis pill approved for NHS useNICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback